Trust in official information as a key predictor of COVID-19 vaccine acceptance: evidence from a Czech longitudinal survey study

COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 25; no. 1; pp. 770 - 11
Main Authors Grygarová, Dominika, Kožený, Jiří, Tišanská, Lýdie, Havlík, Marek, Horáček, Jiří
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 25.02.2025
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1471-2458
1471-2458
DOI10.1186/s12889-025-21988-x

Cover

Loading…
Abstract COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population. A multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407). After controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA. CVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.
AbstractList BackgroundCOVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population.MethodsA multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407).ResultsAfter controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA.ConclusionCVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.
COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population. A multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407). After controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA. CVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.
COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population.BACKGROUNDCOVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population.A multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407).METHODSA multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407).After controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA.RESULTSAfter controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA.CVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.CONCLUSIONCVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.
COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population. A multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407). After controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA. CVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.
Abstract Background COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population. Methods A multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407). Results After controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA. Conclusion CVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation.
Background COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates surrounding vaccines have expanded beyond health considerations to include issues of trust, misinformation, and societal values, making CVH a complex challenge that requires multifaceted solutions. Analyzing the various determinants of CVH is crucial for developing targeted strategies to improve vaccine acceptance in specific countries and to better prepare for future public health crises. However, no study to date has evaluated the determinants of CVH in a representative sample of the Czech population. Methods A multiple hierarchical logistic regression was used to analyze the associations between various sociodemographic, trust and attitudinal factors with COVID-19 vaccine acceptance (CVA). The analysis utilized survey data from a representative longitudinal sample of the Czech population (N = 1,407). Results After controlling for all other factors, trust in official statements from the Ministry of Health was the strongest predictor of CVA, followed by prior positive attitudes toward COVID-19 vaccination (prior to vaccine availability) and older age. Lower trust in COVID-19 misinformation also predicted CVA, while lower interest in COVID-19 media content was associated with CVA. Higher income initially predicted CVA but lost statistical significance after controlling for other variables. Interestingly, education did not play a role in CVA. Conclusion CVH was primarily driven by distrust in government-provided information. Notably, vaccine refusers demonstrated a higher motivation to seek information on the topic, offering a promising opportunity for health policy interventions. Our findings suggest that strategies to reduce CVH should prioritize building trust in state institutions and effectively combating misinformation. Keywords: COVID-19, Vaccine hesitancy, Vaccine acceptance, Trust in institutions, Misinformation
ArticleNumber 770
Audience Academic
Author Kožený, Jiří
Tišanská, Lýdie
Havlík, Marek
Grygarová, Dominika
Horáček, Jiří
Author_xml – sequence: 1
  givenname: Dominika
  surname: Grygarová
  fullname: Grygarová, Dominika
– sequence: 2
  givenname: Jiří
  surname: Kožený
  fullname: Kožený, Jiří
– sequence: 3
  givenname: Lýdie
  surname: Tišanská
  fullname: Tišanská, Lýdie
– sequence: 4
  givenname: Marek
  surname: Havlík
  fullname: Havlík, Marek
– sequence: 5
  givenname: Jiří
  surname: Horáček
  fullname: Horáček, Jiří
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40001023$$D View this record in MEDLINE/PubMed
BookMark eNptkk1v1DAQhiNURD_gD3BAlrj0khI7cexwQdXytVKlXgpXy7HHWy9JvNjJqsuJn87sbql2EfLB4_HjdzTj9zw7GcIAWfaaFleUyvpdokzKJi8YzxltpMwfnmVntBI0ZxWXJwfxaXae0rIoqJCcvchOqwLjgpVn2e-7OKWR-IEE57zxusPYhdjr0YeB6EQ0-QEbsopgvRlDRI7Mbr_PP-a0IWttjB-A4AarUQ8G3hNYewsYERdDj69nv8Dcky4MCz9O1g9YIU1xjZoJz5uX2XOnuwSvHveL7NvnT3ezr_nN7Zf57PomN5zyMbeMOdly0TSWci5YWzdFxZgUwDlrWQ3CibYxTFq84K5itbStM67mVFTWtOVFNt_r2qCXahV9r-NGBe3VLhHiQuk4etOBKjnUJRNSS-CVxVE3vKYSZFUYipUAtT7stVZT24M1MIxRd0eixzeDv1eLsFaoxcuGMVS4fFSI4ecEaVS9Twa6Tg8QpqRKKmgpalFJRN_-gy7DFHGMO4pXBa2bA2qhsYPtF2JhsxVV13JrE16JGqmr_1C4LPTeoLucx_zRgzeHnT61-NdACLA9YGJIKYJ7QmixbbdWe5cqdKnauVQ9lH8AizPX8Q
Cites_doi 10.3390/ijerph182413373
10.1080/21645515.2021.1950504
10.34172/hpp.2023.03
10.1080/21645515.2021.1917233
10.1371/journal.pone.0170550
10.1080/13501763.2021.1942151
10.1016/j.puhe.2021.02.025
10.1111/asap.12291
10.5152/eurasianjmed.2020.20132
10.3389/ijph.2023.1605375
10.3390/vaccines9090948
10.3390/vaccines9030300
10.3389/fpsyt.2021.809239
10.3389/fpsyg.2022.900386
10.1007/s11845-021-02640-0
10.1007/s12144-021-02105-8
10.2196/26874
10.1038/s41591-020-1124-9
10.1016/j.bbi.2021.03.008
10.1080/21645515.2021.1983389
10.2196/preprints.62913
10.1038/s41598-022-16572-x
10.3389/fpubh.2021.665724
10.1111/ijcp.14336
10.1111/1753-6405.13184
10.1038/s41598-022-17430-6
10.3390/vaccines9060593
10.1016/S2214-109X(23)00063-3
10.1016/j.intimp.2021.107724
10.1038/s41746-023-00912-w
10.1080/21645515.2020.1780846
10.1016/j.eclinm.2021.100772
10.1016/j.vaccine.2022.02.059
10.3390/vaccines9121437
10.1371/journal.pone.0258462
10.1186/s12889-015-2541-4
10.32996/jmhs.2024.5.1.8
10.1016/j.eclinm.2022.101454
10.1093/eurpub/ckad160.594
10.1126/sciadv.abm9825
10.1101/2021.01.04.21249241
10.1038/s41467-020-20226-9
10.1037/xap0000315
10.3390/vaccines9101071
10.1093/eurpub/ckad052
10.1038/s41598-023-35974-z
10.1371/journal.pone.0250123
10.3390/vaccines9040379
10.1038/s41598-023-50898-4
10.1080/21645515.2021.1893062
10.3390/vaccines9080900
10.2196/34615
10.1371/journal.pone.0189885
10.1080/21645515.2021.1926183
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-025-21988-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest SciTech Premium Collection Technology Collection Materials Science & Engineering Database
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1471-2458
EndPage 11
ExternalDocumentID oai_doaj_org_article_35e63278a8e54d11895618e840c126ee
PMC11853922
A828895476
40001023
10_1186_s12889_025_21988_x
Genre Journal Article
GeographicLocations Czech Republic
GeographicLocations_xml – name: Czech Republic
GrantInformation_xml – fundername: Grantová Agentura České Republiky
  grantid: 20-13458S
– fundername: Ministerstvo Zdravotnictví Ceské Republiky
  grantid: NU22-D-132
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T2
7XB
8FK
AZQEC
C1K
COVID
DWQXO
GNUQQ
K9.
M48
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-d22f8b5799d15572b69042287e552b26e7f7b9c28d6905f4268dbfcf65174dcb3
IEDL.DBID DOA
ISSN 1471-2458
IngestDate Wed Aug 27 01:28:45 EDT 2025
Thu Aug 21 18:27:45 EDT 2025
Thu Jul 10 21:29:49 EDT 2025
Fri Jul 25 12:21:27 EDT 2025
Tue Jun 17 22:00:26 EDT 2025
Tue Jun 10 21:08:45 EDT 2025
Sun May 11 01:41:45 EDT 2025
Tue Jul 01 05:39:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Misinformation
Trust in institutions
Vaccine acceptance
Vaccine hesitancy
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-d22f8b5799d15572b69042287e552b26e7f7b9c28d6905f4268dbfcf65174dcb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/35e63278a8e54d11895618e840c126ee
PMID 40001023
PQID 3175401698
PQPubID 44782
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_35e63278a8e54d11895618e840c126ee
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11853922
proquest_miscellaneous_3171376748
proquest_journals_3175401698
gale_infotracmisc_A828895476
gale_infotracacademiconefile_A828895476
pubmed_primary_40001023
crossref_primary_10_1186_s12889_025_21988_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-02-25
PublicationDateYYYYMMDD 2025-02-25
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-25
  day: 25
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC public health
PublicationTitleAlternate BMC Public Health
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 21988_CR39
21988_CR38
N Chandeying (21988_CR3) 2023; 6
21988_CR37
K Kricorian (21988_CR11) 2022; 18
SL van der Linden (21988_CR58) 2015; 15
21988_CR36
21988_CR35
21988_CR34
21988_CR33
J Griffith (21988_CR24) 2021; 23
W Jennings (21988_CR48) 2021; 28
S Ahmed (21988_CR27) 2022; 13
R Zidkova (21988_CR14) 2023; 68
A Pandey (21988_CR2) 2023; 11
SB Bass (21988_CR32) 2021; 9
S Salvatore (21988_CR52) 2018; 13
SE Hwang (21988_CR44) 2022; 18
21988_CR49
A Bendau (21988_CR21) 2021; 97
JV Lazarus (21988_CR9) 2021; 27
A Fridman (21988_CR23) 2021; 16
F Cascini (21988_CR29) 2022; 48
Z Turhan (21988_CR41) 2022; 41
J Murphy (21988_CR40) 2021; 12
21988_CR1
J Kaufman (21988_CR42) 2022; 46
A Hudson (21988_CR13) 2021; 18
21988_CR17
21988_CR15
21988_CR59
R Piltch-Loeb (21988_CR60) 2022; 8
V Carrieri (21988_CR18) 2023; 13
21988_CR10
21988_CR54
S van der Linden (21988_CR57) 2021; 33
21988_CR51
21988_CR12
ŞB Nazlı (21988_CR26) 2022; 191
21988_CR56
JI Steinert (21988_CR5) 2022; 8
CS Wiysonge (21988_CR7) 2022; 18
LG Borga (21988_CR45) 2022; 12
EI Novel (21988_CR47) 2024; 5
A Aassve (21988_CR50) 2024; 14
P Gerretsen (21988_CR16) 2021; 16
M Mascherini (21988_CR28) 2022; 40
L Alphonsus (21988_CR43) 2023; 7
L Kesner (21988_CR6) 2021; 12
H İkiışık (21988_CR19) 2021; 75
AL Wagner (21988_CR55) 2021; 17
SK Lee (21988_CR25) 2022; 12
21988_CR22
K Dhama (21988_CR8) 2021; 17
P Schmid (21988_CR4) 2017; 12
G Troiano (21988_CR20) 2021; 194
D Toshkov (21988_CR46) 2023; 33
S Pourrazavi (21988_CR31) 2023; 13
N Puri (21988_CR30) 2020; 16
A Ergur (21988_CR53) 2020; 52
References_xml – ident: 21988_CR35
  doi: 10.3390/ijerph182413373
– volume: 18
  start-page: 1950504
  issue: 1
  year: 2022
  ident: 21988_CR11
  publication-title: Hum Vaccines Immunotherapeutics
  doi: 10.1080/21645515.2021.1950504
– volume: 13
  start-page: 21
  issue: 1
  year: 2023
  ident: 21988_CR31
  publication-title: Health Promotion Perspect
  doi: 10.34172/hpp.2023.03
– ident: 21988_CR37
– volume: 17
  start-page: 2940
  issue: 9
  year: 2021
  ident: 21988_CR55
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2021.1917233
– volume: 12
  start-page: e0170550
  issue: 1
  year: 2017
  ident: 21988_CR4
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0170550
– volume: 28
  start-page: 1174
  issue: 8
  year: 2021
  ident: 21988_CR48
  publication-title: J Eur Public Policy
  doi: 10.1080/13501763.2021.1942151
– volume: 194
  start-page: 245
  year: 2021
  ident: 21988_CR20
  publication-title: Public Health
  doi: 10.1016/j.puhe.2021.02.025
– ident: 21988_CR51
  doi: 10.1111/asap.12291
– volume: 52
  start-page: 217
  issue: 2
  year: 2020
  ident: 21988_CR53
  publication-title: Eurasian J Med
  doi: 10.5152/eurasianjmed.2020.20132
– volume: 68
  start-page: 1605375
  year: 2023
  ident: 21988_CR14
  publication-title: Int J Public Health
  doi: 10.3389/ijph.2023.1605375
– ident: 21988_CR36
  doi: 10.3390/vaccines9090948
– ident: 21988_CR15
  doi: 10.3390/vaccines9030300
– volume: 12
  start-page: 809239
  year: 2021
  ident: 21988_CR6
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2021.809239
– volume: 13
  start-page: 900386
  year: 2022
  ident: 21988_CR27
  publication-title: Front Psychol
  doi: 10.3389/fpsyg.2022.900386
– volume: 191
  start-page: 71
  issue: 1
  year: 2022
  ident: 21988_CR26
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-021-02640-0
– volume: 41
  start-page: 8147
  issue: 11
  year: 2022
  ident: 21988_CR41
  publication-title: Curr Psychol
  doi: 10.1007/s12144-021-02105-8
– volume: 23
  start-page: e26874
  issue: 4
  year: 2021
  ident: 21988_CR24
  publication-title: J Med Internet Res
  doi: 10.2196/26874
– volume: 27
  start-page: 225
  issue: 2
  year: 2021
  ident: 21988_CR9
  publication-title: Nat Med
  doi: 10.1038/s41591-020-1124-9
– ident: 21988_CR12
  doi: 10.1016/j.bbi.2021.03.008
– volume: 18
  start-page: 1
  issue: 1
  year: 2022
  ident: 21988_CR44
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2021.1983389
– volume: 18
  start-page: 15
  year: 2021
  ident: 21988_CR13
  publication-title: Int J Environ Res Public Health [Internet]
– ident: 21988_CR33
  doi: 10.2196/preprints.62913
– volume: 12
  start-page: 12435
  issue: 1
  year: 2022
  ident: 21988_CR45
  publication-title: Sci Rep
  doi: 10.1038/s41598-022-16572-x
– volume: 9
  start-page: 665724
  year: 2021
  ident: 21988_CR32
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2021.665724
– volume: 75
  start-page: e14336
  issue: 8
  year: 2021
  ident: 21988_CR19
  publication-title: Int J Clin Pract
  doi: 10.1111/ijcp.14336
– volume: 46
  start-page: 16
  issue: 1
  year: 2022
  ident: 21988_CR42
  publication-title: Aust N Z J Public Health
  doi: 10.1111/1753-6405.13184
– volume: 12
  start-page: 13681
  issue: 1
  year: 2022
  ident: 21988_CR25
  publication-title: Sci Rep
  doi: 10.1038/s41598-022-17430-6
– ident: 21988_CR22
  doi: 10.3390/vaccines9060593
– volume: 11
  start-page: e478
  issue: 4
  year: 2023
  ident: 21988_CR2
  publication-title: Lancet Global Health
  doi: 10.1016/S2214-109X(23)00063-3
– volume: 97
  start-page: 107724
  year: 2021
  ident: 21988_CR21
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.107724
– volume: 6
  start-page: 162
  issue: 1
  year: 2023
  ident: 21988_CR3
  publication-title: Npj Digit Med
  doi: 10.1038/s41746-023-00912-w
– volume: 16
  start-page: 2586
  issue: 11
  year: 2020
  ident: 21988_CR30
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2020.1780846
– ident: 21988_CR39
– volume: 33
  start-page: 100772
  year: 2021
  ident: 21988_CR57
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2021.100772
– volume: 40
  start-page: 2215
  issue: 14
  year: 2022
  ident: 21988_CR28
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2022.02.059
– ident: 21988_CR34
  doi: 10.3390/vaccines9121437
– volume: 16
  start-page: e0258462
  issue: 11
  year: 2021
  ident: 21988_CR16
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0258462
– volume: 7
  start-page: 1
  year: 2023
  ident: 21988_CR43
  publication-title: Journal
– volume: 15
  start-page: 1207
  issue: 1
  year: 2015
  ident: 21988_CR58
  publication-title: BMC Public Health
  doi: 10.1186/s12889-015-2541-4
– volume: 5
  start-page: 57
  issue: 1
  year: 2024
  ident: 21988_CR47
  publication-title: J Med Health Stud
  doi: 10.32996/jmhs.2024.5.1.8
– volume: 48
  start-page: 101454
  year: 2022
  ident: 21988_CR29
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2022.101454
– ident: 21988_CR49
  doi: 10.1093/eurpub/ckad160.594
– volume: 8
  start-page: eabm9825
  issue: 17
  year: 2022
  ident: 21988_CR5
  publication-title: Sci Adv
  doi: 10.1126/sciadv.abm9825
– ident: 21988_CR54
  doi: 10.1101/2021.01.04.21249241
– ident: 21988_CR38
– volume: 12
  start-page: 29
  issue: 1
  year: 2021
  ident: 21988_CR40
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-20226-9
– ident: 21988_CR59
  doi: 10.1037/xap0000315
– ident: 21988_CR1
– ident: 21988_CR10
  doi: 10.3390/vaccines9101071
– volume: 33
  start-page: 490
  issue: 3
  year: 2023
  ident: 21988_CR46
  publication-title: Eur J Pub Health
  doi: 10.1093/eurpub/ckad052
– volume: 13
  start-page: 9245
  issue: 1
  year: 2023
  ident: 21988_CR18
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-35974-z
– volume: 16
  start-page: e0250123
  issue: 4
  year: 2021
  ident: 21988_CR23
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0250123
– ident: 21988_CR56
  doi: 10.3390/vaccines9040379
– volume: 14
  start-page: 331
  issue: 1
  year: 2024
  ident: 21988_CR50
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-50898-4
– volume: 18
  start-page: 1
  issue: 1
  year: 2022
  ident: 21988_CR7
  publication-title: Hum Vaccines Immunotherapeutics
  doi: 10.1080/21645515.2021.1893062
– ident: 21988_CR17
  doi: 10.3390/vaccines9080900
– volume: 8
  start-page: e34615
  issue: 6
  year: 2022
  ident: 21988_CR60
  publication-title: JMIR Public Health Surveill
  doi: 10.2196/34615
– volume: 13
  start-page: e0189885
  issue: 1
  year: 2018
  ident: 21988_CR52
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0189885
– volume: 17
  start-page: 3495
  issue: 10
  year: 2021
  ident: 21988_CR8
  publication-title: Hum Vaccines Immunotherapeutics
  doi: 10.1080/21645515.2021.1926183
SSID ssj0017852
Score 2.44452
Snippet COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public debates...
Background COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue....
BackgroundCOVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social issue. Public...
Abstract Background COVID-19 vaccine hesitancy (CVH) has become a critical public health issue, with attitudes toward vaccines emerging as a broader social...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 770
SubjectTerms Acceptance
Adolescent
Adult
Age
Aged
Analysis
Attitudes
COVID-19
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - administration & dosage
Czech Republic
Epidemics
False information
Female
Health education
Health Knowledge, Attitudes, Practice
Health literacy
Health policy
Health surveys
Humans
Information sources
Longitudinal Studies
Male
Middle Aged
Misinformation
Pandemics
Patient Acceptance of Health Care - psychology
Peers
Perceptions
Population
Public health
Social aspects
Social media
Sociodemographics
Statistical analysis
Surveys
Surveys and Questionnaires
Trust - psychology
Trust in institutions
Trustworthiness
Vaccination
Vaccination Hesitancy - psychology
Vaccination Hesitancy - statistics & numerical data
Vaccine acceptance
Vaccine hesitancy
Vaccines
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96vggifls9JYLgg4Tbpkma-iLn6nEK6sud7FtovrwDadf9OA6f_NOdSdP1iuDTQjPtpp2ZzEwy8xtCXjahrJVoOGvbsmEiWsvaWEYmy9iWlVNBpK2Lz1_U8an4tJCLvOG2zmmV45qYFmrfO9wjP0A7JxA6RL9d_mTYNQpPV3MLjevkBkKXYUpXvdgFXNh4no-FMlodrGEtxgQhLhnoKUjI5cQYJcz-f1fmK6ZpmjZ5xQ4d3SG3swNJDweO3yXXQneP3Bp23-hQVHSf_D7BUgp63tERIoJmhFTkA23XtKWgvXS5wnMaCLuBjs6_fvv4npUNvWgdHrdT-AnLDYrFGxpy91GK9Shw9_xXcGf0R4_tjrYeW2vR9XZ1Ac9MgLUPyOnRh5P5Mcu9FpgDj2bDPOdRW1k3jQcPo-YWomZEB6uDlNxyFepY28Zx7WFARrDr2tvookKka-9s9ZDsdX0XHhMKJCEGZZuSOxG8b6Vys6B1sE0Uzs8K8nr86GY5QGqYFIpoZQYWGWCRSSwylwV5h3zZUSIcdrrQr76brF2mkkFVvNatDlJ4eBKW6-oAwasrYe6hIK-QqwY_NbDOtbn2ACaM8FfmUOPfSlGrguxPKEHZ3HR4lAuTlX1t_opmQV7shvFOTGDrQr9NNCUC5wigeTSI0e6VxCwh-1UF0RMBm7zzdKQ7P0tQ4CW6Ww3nT_4_r6fkJkexx1J8uU_2NqtteAbO1MY-TxrzBw-DHrI
  priority: 102
  providerName: ProQuest
Title Trust in official information as a key predictor of COVID-19 vaccine acceptance: evidence from a Czech longitudinal survey study
URI https://www.ncbi.nlm.nih.gov/pubmed/40001023
https://www.proquest.com/docview/3175401698
https://www.proquest.com/docview/3171376748
https://pubmed.ncbi.nlm.nih.gov/PMC11853922
https://doaj.org/article/35e63278a8e54d11895618e840c126ee
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxNBEF-0vggi9ftsDSsIPsjR7N5-nW9NbKyCVUorwZfl9osW5BLyUYpP_unO3F1CDh988WUD2bnkbj52Zm53fkPImzIyrUTJ86piZS6Sc3mVWMolSxUrvIqieXXx5UydXorPUzndafWFZ8JaeOCWcUeFjKrg2lQmShEgHMZKTBMhL_GMqxhx9QWft0mmuv0DbSTflMgYdbSEVRiPBnGZg4WCbtz23FCD1v_3mrzjlPoHJnc80GSfPOxCR3rc3vIjcifWj8mD9r0bbcuJnpDfF1hEQa9rugGHoB02KkqAVktaUbBbOl_gDg0k3EBHx1-_f_qQs5LeVB432il8xPkKFeI9jV3fUYqVKHD1-Ff0V_TnDBsdrQM21aLL9eIGfrOBqn1KLicnF-PTvOuykHuIZVZ54DwZJ3VZBogtNHeQLyMumI5Scgcs1km70nMTYEIm8OgmuOSTQozr4F3xjOzVszq-IBRIYorKlYx7EUOopPLDaEx0ZRI-DDPybsN0O2_BNGyThBhlWxFZEJFtRGRvMzJCuWwpEQi7-QLUw3bqYf-lHhl5i1K1yGoQna-6qgO4YQS-sscG_1YKrTJy2KMEM_P96Y1e2M7MlxaDL4F4NiYjr7fTeCUeXavjbN3QMITMEUDzvFWj7SOJYYPpV2TE9BSs98z9mfr6qgEBZxholZy__B9cOiD3ORoHlurLQ7K3WqzjKwi2Vm5A7uqphtGMGY6TjwNyb3Ry9u180FgcjOejH38Aom0rIg
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOYCEEG8CBYwE4oCibry24yAhVLZUu_TBZYt6c-MXrYSyyz5K4cQv4jcy4yRLIyRuPUWKJ46TeXlszzeEvCh8lktesLQssyLlwZi0DFlIRRbKrG-l53HpYv9ADg_5xyNxtEZ-t7kweKyytYnRULuJxTXyTfRzHKFD1LvptxSrRuHualtCoxaLXf_jO4Rs87ejbeDvS8Z2PowHw7SpKpBa8N2L1DEWlBF5UTjwpTkzEB8iDlbuhWCGSZ-H3BSWKQcNIoAHU84EGyRiOjtr-tDvFXIVHG8PNSo_WgV4WOietYk5Sm7OwfbjgSQmUrALIJHnHecXawT86wkuuMLuMc0Lfm_nFrnZTFjpVi1ht8mar-6QG_VqH62TmO6SX2NM3aCnFW0hKWiDyIp8p-WclhSsBZ3OcF8Iwnygo4NPn0fbaVbQs9Li9j6Fi58uUAzfUN9UO6WY_wJPD356e0K_TrC80tJhKS86X87OoM8IkHuPHF4KF-6T9WpS-YeEAokPXpoiY5Z750ohbc8r5U0RuHW9hLxuf7qe1hAeOoY-SuqaRRpYpCOL9HlC3iNfVpQIvx1vTGZfdKPNui-87LNclcoL7qAnTA9WHoJlm8HYfUJeIVc1_mpgnS2bXAcYMMJt6S2FrxU8lwnZ6FCCcttucysXujEuc_1XFRLyfNWMT-KBucpPlpEmQ6AeDjQPajFafRLvRSTBfkJUR8A639xtqU5PIvR4htO7grFH_x_XM3JtON7f03ujg93H5DpDFUAYALFB1hezpX8CE7mFeRq1h5Ljy1bXPz08Wnc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trust+in+official+information+as+a+key+predictor+of+COVID-19+vaccine+acceptance%3A+evidence+from+a+Czech+longitudinal+survey+study&rft.jtitle=BMC+public+health&rft.au=Grygarov%C3%A1%2C+Dominika&rft.au=Ko%C5%BEen%C3%BD%2C+Ji%C5%99%C3%AD&rft.au=Ti%C5%A1ansk%C3%A1%2C+L%C3%BDdie&rft.au=Havl%C3%ADk%2C+Marek&rft.date=2025-02-25&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12889-025-21988-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12889_025_21988_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon